NCT04324905View on ClinicalTrials.gov

Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP1802 to HGP1705 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

April 29, 2020

Primary Completion Date

October 30, 2020

Study Completion Date

October 30, 2020

Conditions
Healthy Volunteer
Interventions
DRUG

HIP1802

Test drug

DRUG

HGP1705

Reference drug

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT04324905 - Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP1802 to HGP1705 in Healthy Volunteers | Biotech Hunter | Biotech Hunter